ANNA ALLMAN: Open Payments
NPI 1427328681 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 8 payments from 6 companies in 2025. Trend: 2023 $261 · 2024 $114 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Lilly USA, LLC | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: TRELEGY ELLIPTA, MOUNJARO, FRUZAQLA, FARXIGA, GVOKE HYPOPEN, AIRSUPRA, Ozempic.
Industry payments across SC — which companies pay providers there.
